{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:38:29Z","timestamp":1783485509512,"version":"3.55.0"},"reference-count":252,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jaad.2015.05.026","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T23:36:38Z","timestamp":1435880198000},"page":"672-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Evidence-based approach to cutaneous hyperandrogenism in women"],"prefix":"10.1016","volume":"73","author":[{"given":"Timothy H.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanade","family":"Shinkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jaad.2015.05.026_bib1","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jaad.2015.05.026_bib2","first-page":"1297","article-title":"Cutaneous hyperandrogenism: role of antiandrogen therapy in acne, hirsutism, and androgenetic alopecia","volume":"12","author":"Krausz","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/derm.1.2.8354","article-title":"Hormones and the pilosebaceous unit","volume":"1","author":"Chen","year":"2009","journal-title":"Dermatoendocrinol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2015.05.026_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0190-9622(93)70092-8","article-title":"Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. I","volume":"28","author":"Sperling","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-2133.2005.06426.x","article-title":"A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome","volume":"152","author":"Clayton","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-2133.1999.02768.x","article-title":"The quality of life in acne: a comparison with general medical conditions using generic questionnaires","volume":"140","author":"Mallon","year":"1999","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-3083.2001.00229.x","article-title":"The effect of hair loss on quality of life","volume":"15","author":"Williamson","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2015.05.026_bib8","first-page":"995","article-title":"The evaluation and management of hirsutism","volume":"101","author":"Azziz","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2340\/00015555-1164","article-title":"Prevalence of acne vulgaris in Chinese adolescents and adults: a community-based study of 17,345 subjects in six cities","volume":"92","author":"Shen","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/jwh.2010.2722","article-title":"Acne vulgaris in women: prevalence across the life span","volume":"21","author":"Perkins","year":"2002","journal-title":"J Womens Health"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1087-0024.2005.10102.x","article-title":"Prevalence of male and female pattern hair loss in Maryborough","volume":"10","author":"Gan","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib12","first-page":"53","article-title":"Incidence of female androgenetic alopecia (female pattern alopecia)","volume":"27","author":"Norwood","year":"2001","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1749-6632.1951.tb31971.x","article-title":"Patterned loss of hair in man; types and incidence","volume":"53","author":"Hamilton","year":"1951","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2001.04289.x","article-title":"The prevalence and types of androgenetic alopecia in Korean men and women","volume":"145","author":"Paik","year":"2001","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archderm.1987.01660260079018","article-title":"The relationship of mild hirsutism or acne in women to androgens","volume":"123","author":"Reingold","year":"1987","journal-title":"Arch Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2015.05.026_bib16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0190-9622(88)70241-8","article-title":"The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia","volume":"19","author":"Futterweit","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0034-1371091","article-title":"Diagnosis and challenges of polycystic ovary syndrome in adolescence","volume":"32","author":"Agapova","year":"2014","journal-title":"Semin Reprod Med"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/met.2010.0039","article-title":"Polycystic ovary syndrome in the pediatric population","volume":"8","author":"Bremer","year":"2010","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jaad.2015.05.026_bib19","doi-asserted-by":"crossref","unstructured":"Kamangar F, Okhovat JP, Schmidt T, et al. Polycystic ovary\u00a0syndrome: special diagnostic and therapeutic considerations for children. Pediatr Dermatol. doi:10.1111\/pde.12566. Published online March 19, 2015.","DOI":"10.1111\/pde.12566"},{"key":"10.1016\/j.jaad.2015.05.026_bib20","doi-asserted-by":"crossref","unstructured":"Witchel SF, Oberfield S, Rosenfield RL, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. doi:10.1159\/000375530. Published online April 1, 2015.","DOI":"10.1159\/000375530"},{"issue":"24","key":"10.1016\/j.jaad.2015.05.026_bib21","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1056\/NEJMcp033496","article-title":"Clinical practice. Hirsutism","volume":"353","author":"Rosenfield","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/md.0b013e3181946a2c","article-title":"Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism","volume":"88","author":"Karrer-Voegeli","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1210\/jcem-59-3-471","article-title":"Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women","volume":"59","author":"Steinberger","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib24","first-page":"84","article-title":"Dermatologic manifestation of hyperandrogenism: a retrospective chart review","volume":"12","author":"Clark","year":"2014","journal-title":"Skinmed"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib25","first-page":"105","article-title":"Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome","volume":"21","author":"Pavi\u010di\u0107 Baldani","year":"2013","journal-title":"Acta Dermatovenerol Croat"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0022-4731(86)90359-6","article-title":"Studies\u00a0of androgen metabolism and action in cultured hair and skin cells","volume":"24","author":"Maudelonde","year":"1986","journal-title":"J Steroid Biochem"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1210\/jcem-38-5-811","article-title":"Regulation of human hair growth\u00a0by steroid hormones. I. Testerone metabolism in isolated hairs","volume":"38","author":"Schweikert","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1523-1747.2003.12181.x","article-title":"The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unit","volume":"8","author":"Thornton","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1330467","article-title":"Localization of androgen receptors in human\u00a0skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands","volume":"133","author":"Choudhry","year":"1992","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1677\/joe.0.1560059","article-title":"Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp","volume":"156","author":"Hibberts","year":"1998","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1087-0024.2005.10106.x","article-title":"Hirsutism and the variable response of the pilosebaceous unit to androgen","volume":"10","author":"Rosenfield","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.0906-6705.2005.0285a.x","article-title":"What is the pathogenesis of acne?","volume":"14","author":"Zouboulis","year":"2005","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clindermatol.2004.03.010","article-title":"Acne: hormonal concepts and therapy","volume":"22","author":"Thiboutot","year":"2004","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.det.2006.01.002","article-title":"Antiandrogen therapy for skin and hair disease","volume":"24","author":"Harper","year":"2006","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/1523-1747.ep12676718","article-title":"The skin microflora in acne vulgaris","volume":"62","author":"Marples","year":"1974","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib36","first-page":"524","article-title":"The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity","volume":"76","author":"Imperato-McGinley","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"1A","key":"10.1016\/j.jaad.2015.05.026_bib37","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1016\/S0002-9343(99)80064-3","article-title":"Hormonal correlates of acne and hirsutism","volume":"98","author":"Lucky","year":"1995","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/archderm.1994.01690030040006","article-title":"Acne vulgaris in premenarchal girls. An early sign of puberty associated with rising levels of dehydroepiandrosterone","volume":"130","author":"Lucky","year":"1994","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2015.05.026_bib40","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-4632.2007.03411.x","article-title":"Assessment of androgens in women with adult-onset acne","volume":"46","author":"Seirafi","year":"2007","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3476(97)70307-X","article-title":"Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study","volume":"130","author":"Lucky","year":"1997","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.sder.2008.06.002","article-title":"Hormonal therapy for acne","volume":"27","author":"George","year":"2008","journal-title":"Semin Cutan Med Surg"},{"issue":"10","key":"10.1016\/j.jaad.2015.05.026_bib43","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1365-4632.2012.05519.x","article-title":"Acne in the adult female patient: a practical approach","volume":"51","author":"Kamangar","year":"2012","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2015.05.026_bib44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/jdv.12061","article-title":"Adult female acne: a new paradigm","volume":"27","author":"Dr\u00e9no","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib45","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1210\/jc.2004-1677","article-title":"Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss","volume":"90","author":"Choi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib46","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/jc.2005-2596","article-title":"Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study","volume":"91","author":"Miller","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2015.05.026_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00926230252851285","article-title":"Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results","volume":"28","author":"Munarriz","year":"2002","journal-title":"J Sex Marital Ther"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJMra022251","article-title":"Risks of testosterone-replacement therapy and recommendations for monitoring","volume":"350","author":"Rhoden","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/00015550410023248","article-title":"Correlation between endocrinological parameters and acne severity in adult women","volume":"84","author":"Borgia","year":"2004","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/17469872.2013.814858","article-title":"An update on diagnosis and treatment of female pattern hair loss","volume":"8","author":"Mubki","year":"2013","journal-title":"Expert Rev Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1523-1747.2003.12168.x","article-title":"Androgenetic alopecia in women","volume":"8","author":"Price","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib52","first-page":"703","article-title":"The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness","volume":"79","author":"Dallob","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib53","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1523-1747.ep12335779","article-title":"Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia","volume":"109","author":"Sawaya","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib54","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.fertnstert.2014.01.003","article-title":"Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features","volume":"101","author":"Quinn","year":"2014","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3949\/ccjm.50.2.111","article-title":"Adrenal androgenic female-pattern alopecia: sex hormones and the balding woman","volume":"50","author":"Kasick","year":"1983","journal-title":"Cleve Clin Q"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.1982.tb01732.x","article-title":"Low sex-hormone binding globulin levels in young women with diffuse hair loss","volume":"106","author":"Miller","year":"1982","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2015.05.026_bib57","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/archderm.1986.01660210061019","article-title":"Female androgenic alopecia. The 3 alpha,17 beta-androstanediol glucuronide\/sex hormone binding globulin ratio as a possible marker for female pattern baldness","volume":"122","author":"De Villez","year":"1986","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib58","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive\u00a0clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib60","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s12020-014-0340-9","article-title":"Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients","volume":"48","author":"Albu","year":"2015","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib61","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2013.11.027","article-title":"Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome","volume":"101","author":"Sung","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib62","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jaad.2015.05.026_bib63","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.jaad.2015.05.026_bib65","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2265.1994.tb02535.x","article-title":"A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia","volume":"41","author":"O'Driscoll","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"785","key":"10.1016\/j.jaad.2015.05.026_bib67","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/pgmj.67.785.304","article-title":"Virilization in a postmenopausal woman due to ovarian stromal hyperthecosis","volume":"67","author":"Goldman","year":"1991","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib68","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.jaad.2015.05.026_bib69","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJM199410133311502","article-title":"Identification of virilizing adrenal tumors in hirsute women","volume":"331","author":"Derksen","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jaad.2015.05.026_bib70","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-198508000-00001","article-title":"Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases","volume":"9","author":"Young","year":"1985","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.jaad.2015.05.026_bib71","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00000478-198711000-00002","article-title":"Ovarian steroid cell tumors (not otherwise specified). A clinicopathological analysis of 63 cases","volume":"11","author":"Hayes","year":"1987","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.jaad.2015.05.026_bib72","first-page":"786","article-title":"Androgenic granulosa cell tumors of the ovary. A clinicopathologic analysis of 17 cases and review of the literature","volume":"108","author":"Nakashima","year":"1984","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.jaad.2015.05.026_bib73","first-page":"1241","article-title":"Androgenic alopecia revealing an androgen secreting ovarian tumor [in French]","volume":"128","author":"Roux-Guinot","year":"2001","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib74","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/uog.6131","article-title":"Ovarian hyperthecosis on grayscale and color Doppler ultrasound","volume":"32","author":"Rousset","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib75","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.jaad.2015.05.026_bib76","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib77","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1067\/mob.2000.108020","article-title":"21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study","volume":"183","author":"Moran","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib78","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/jcem-55-2-251","article-title":"Multiple\u00a0androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women","volume":"55","author":"Glickman","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib79","first-page":"459","article-title":"Clinical diagnosis of hirsutism in Thai women","volume":"87","author":"Cheewadhanaraks","year":"2004","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib80","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/jdv.12432","article-title":"Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients","volume":"29","author":"Hong","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib81","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1479-828X.2001.tb01210.x","article-title":"The impact of ethnicity on the presentation of polycystic ovarian syndrome","volume":"41","author":"Williamson","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib82","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does\u00a0ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2015.05.026_bib83","doi-asserted-by":"crossref","unstructured":"Mani H, Davies MJ, Bodicoat DH, et al. Clinical characteristics of polycystic ovary syndrome: investigating differences in\u00a0white and South Asian women. Clin Endocrinol (Oxf). doi:10.1111\/cen.12784. Published online March 30, 2015.","DOI":"10.1111\/cen.12784"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib84","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/jc.2004-2301","article-title":"Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism","volume":"91","author":"DeUgarte","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib85","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1210\/jcem-72-6-1242","article-title":"Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects","volume":"72","author":"Lookingbill","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib86","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/humrep\/des028","article-title":"Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors","volume":"27","author":"Sanch\u00f3n","year":"2012","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib87","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.fertnstert.2013.03.010","article-title":"Phenotypic comparison of Caucasian and Asian women with polycystic ovary syndrome: a cross-sectional study","volume":"100","author":"Wang","year":"2013","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.jaad.2015.05.026_bib88","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/OGX.0b013e3181f8c41d","article-title":"Pregnancy luteomas: clinical presentations and management strategies","volume":"65","author":"Masarie","year":"2010","journal-title":"Obstet Gynecol Surv"},{"issue":"Suppl 5","key":"10.1016\/j.jaad.2015.05.026_bib89","first-page":"1303","article-title":"Family history as a risk factor for the polycystic ovary syndrome","volume":"13","author":"Azziz","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib90","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2230.1996.tb00109.x","article-title":"How far should we investigate diffuse alopecia in women?","volume":"21","author":"Dupont","year":"1996","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib91","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2008.07.001","article-title":"Medical treatments for male and female pattern hair loss","volume":"59","author":"Rogers","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.05.026_bib92","doi-asserted-by":"crossref","unstructured":"Schmidt T., Khanijow K., Cedars M., et\u00a0al. Cutaneous findings and systemic associations in a cohort of women with polycystic ovary syndrome. Manuscript in preparation. June 2015.","DOI":"10.1001\/jamadermatol.2015.4498"},{"key":"10.1016\/j.jaad.2015.05.026_bib93","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jaad.2015.05.026_bib94","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib95","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1210\/jcem-31-5-556","article-title":"Familial study of hirsutism","volume":"31","author":"Lorenzo","year":"1970","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jaad.2015.05.026_bib96","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1210\/jc.2004-2243","article-title":"Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome","volume":"90","author":"Wild","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2015.05.026_bib97","unstructured":"Pasch L, He S, Wang E, et\u00a0al. Patient-reported impact of hirsutism on health-related quality of life, mood and self-esteem in patients with polycystic ovary syndrome. Manuscript in preparation. June 2015."},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib98","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1067\/mjd.2003.100","article-title":"Hypertrichosis","volume":"48","author":"Wendelin","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib99","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0378-6323.51258","article-title":"Scoring systems in acne vulgaris","volume":"75","author":"Adityan","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib101","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1067\/mjd.2003.81","article-title":"Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss","volume":"48","author":"Olsen","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2015.05.026_bib102","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0190-9622(88)70108-5","article-title":"Patterned androgenic alopecia in women","volume":"18","author":"Venning","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"14","key":"10.1016\/j.jaad.2015.05.026_bib103","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib104","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0015-0282(16)56599-6","article-title":"The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response","volume":"61","author":"Azziz","year":"1994","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0026-0495(86)90201-5","article-title":"Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess","volume":"35","author":"Stuart","year":"1986","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib106","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0733-8635(05)70397-1","article-title":"Photographic documentation of hair growth in androgenetic alopecia","volume":"14","author":"Canfield","year":"1996","journal-title":"Dermatol Clin"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2015.05.026_bib107","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.0926-9959.2001.00007.x","article-title":"New photographic techniques for clinical evaluation of acne","volume":"15","author":"Rizova","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib108","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0190-9622(87)70166-2","article-title":"Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin","volume":"17","author":"Rubinow","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.05.026_bib109","doi-asserted-by":"crossref","unstructured":"Annag\u00fcr BB, Kerimoglu \u00d6S, Tazeg\u00fcl A, G\u00fcnd\u00fcz \u015e, Gen\u00e7oglu BB. Psychiatric comorbidity in women with polycystic ovary syndrome. J Obstet Gynaecol Res. doi:10.1111\/jog.12696. Published online April 1, 2015.","DOI":"10.1111\/jog.12696"},{"key":"10.1016\/j.jaad.2015.05.026_bib110","doi-asserted-by":"crossref","unstructured":"Guidi J, Gambineri A, Zanotti L, Fanelli F, Fava GA, Pasquali R. Psychological aspects of hyperandrogenic states in late\u00a0adolescent and young women. Clin Endocrinol (Oxf). doi:10.1111\/cen.12783. Published online March 30, 2015.","DOI":"10.1111\/cen.12783"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib111","doi-asserted-by":"crossref","first-page":"e0123608","DOI":"10.1371\/journal.pone.0123608","article-title":"Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women","volume":"10","author":"Khomami","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib112","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4274\/jcrpe.1515","article-title":"Social anxiety, depression and self-esteem in obese adolescent girls with acanthosis nigricans","volume":"7","author":"Pirgon","year":"2015","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib113","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP.7.2.120","article-title":"American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of\u00a0hyperandrogenic disorders","volume":"7","author":"Goodman","year":"2001","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib114","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jcem-32-6-717","article-title":"Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects","volume":"32","author":"Rosenfield","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib115","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1210\/jcem-49-5-730","article-title":"Testosterone binding and free plasma androgen concentrations under physiological conditions: characterization by flow dialysis technique","volume":"49","author":"Moll","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2015.05.026_bib116","unstructured":"US Preventive Services Task Force. Draft recommendation statement: abnormal glucose and type 2 diabetes mellitus in adults: screening. Available from: URL: http:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementDraft\/screening-for-abnormal-glucose-and-type-2-diabetes-mellitus. Accessed March 26, 2015."},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib117","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.1999.00886.x","article-title":"Polycystic ovaries and associated clinical and biochemical features in young women","volume":"51","author":"Michelmore","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib118","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2265.1992.tb02296.x","article-title":"How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?","volume":"37","author":"Clayton","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib119","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1479-828X.1994.tb01041.x","article-title":"The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women","volume":"34","author":"Farquhar","year":"1994","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1600-0412.1999.780212.x","article-title":"The prevalence of polycystic ovaries in healthy women","volume":"78","author":"Koivunen","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib121","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1479-828X.2005.00334.x","article-title":"Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia","volume":"45","author":"Lowe","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8590","key":"10.1016\/j.jaad.2015.05.026_bib122","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2013a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib123","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"9","key":"10.1016\/j.jaad.2015.05.026_bib124","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"10.1016\/j.jaad.2015.05.026_bib125","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1200\/JCO.2007.11.1005","article-title":"Management of ovarian stromal cell tumors","volume":"25","author":"Colombo","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib126","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/fampra\/14.2.160","article-title":"A systematic review of the effectiveness of promoting lifestyle change in general practice","volume":"14","author":"Ashenden","year":"1997","journal-title":"Fam Pract"},{"issue":"7","key":"10.1016\/j.jaad.2015.05.026_bib127","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1A","key":"10.1016\/j.jaad.2015.05.026_bib128","doi-asserted-by":"crossref","first-page":"130S","DOI":"10.1016\/S0002-9343(99)80071-0","article-title":"The role of oral contraceptives in the treatment of hyperandrogenic disorders","volume":"98","author":"Burkman","year":"1995","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-992926","article-title":"Polycystic ovary syndrome and endometrial cancer","volume":"26","author":"Navaratnarajah","year":"2008","journal-title":"Semin Reprod Med"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib130","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bjc.1995.260","article-title":"Endometrial and ovarian cancer and oral contraceptives\u2013findings in a large cohort study","volume":"71","author":"Vessey","year":"1995","journal-title":"Br J Cancer"},{"issue":"RR-4","key":"10.1016\/j.jaad.2015.05.026_bib131","first-page":"1","article-title":"US medical eligibility criteria for contraceptive use, 2010","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2015.05.026_bib132","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2015.05.026_bib133","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.jaad.2015.05.026_bib134","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1701-2163(16)34746-6","article-title":"SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update","volume":"32","author":"Reid","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"issue":"10","key":"10.1016\/j.jaad.2015.05.026_bib135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2015.05.026_bib136","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"7","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"10.1016\/j.jaad.2015.05.026_bib137","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp030751","article-title":"Clinical practice. Combination estrogen-progestin oral contraceptives","volume":"349","author":"Petitti","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib138","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.clindermatol.2014.05.002","article-title":"Contraceptive use in acne","volume":"32","author":"Lam","year":"2014","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib139","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-5347(01)66596-0","article-title":"Flutamide hepatotoxicity","volume":"155","author":"Wysowski","year":"1996","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib140","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.fertnstert.2012.06.018","article-title":"Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females","volume":"98","author":"Bruni","year":"2012","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.jaad.2015.05.026_bib141","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrendo.2010.119","article-title":"Therapy: low-dose flutamide for hirsutism: into the limelight, at last","volume":"6","author":"De Zegher","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib142","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/EJE-10-0100","article-title":"Retrospective observational study on the effects and tolerability of flutamide in a large population of patients with various kinds of hirsutism over a 15-year period","volume":"163","author":"Paradisi","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib143","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib144","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mjd.2002.122192","article-title":"Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial","volume":"47","author":"Leyden","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib146","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial","volume":"77","author":"Koltun","year":"2008","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib147","first-page":"143","article-title":"A combined oral contraceptive containing 3-mg drospirenone\/20-microg ethinyl estradiol in the treatment of acne vulgaris: a\u00a0randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment","volume":"82","author":"Lucky","year":"2008","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib148","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0b013e318187e1c5","article-title":"Treatment of acne using a 3-milligram drospirenone\/20-microgram ethinyl estradiol oral contraceptive administered in a 24\/4 regimen: a randomized controlled trial","volume":"112","author":"Maloney","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib149","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-3083.2005.01072.x","article-title":"Effects and side-effects of spironolactone therapy in women with acne","volume":"19","author":"Yemisci","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib150","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mjd.2000.105557","article-title":"Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients","volume":"43","author":"Shaw","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib151","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2133.1985.tb02305.x","article-title":"Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia","volume":"112","author":"Burke","year":"1985","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib152","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00266-006-0081-0","article-title":"Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians","volume":"30","author":"Sato","year":"2006","journal-title":"Aesthetic Plast Surg"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib153","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib154","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","article-title":"Oral spironolactone: an effective treatment for acne vulgaris in women","volume":"115","author":"Muhlemann","year":"1986","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","article-title":"Oral spironolactone improves acne vulgaris and reduces sebum excretion","volume":"111","author":"Goodfellow","year":"1984","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2015.05.026_bib156","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1468-3083.2010.03926.x","article-title":"Importance of spironolactone in the treatment of acne in adult women","volume":"25","author":"Saint-Jean","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib157","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2007.09.024","article-title":"Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone","volume":"58","author":"Krunic","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.05.026_bib158","first-page":"CD007628","article-title":"Interventions for female pattern hair loss","volume":"5","author":"Van Zuuren","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2015.05.026_bib159","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib160","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.jidsp.5640230","article-title":"Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women","volume":"4","author":"Whiting","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib161","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib162","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0022-4731(75)90311-8","article-title":"Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism","volume":"6","author":"Hammerstein","year":"1975","journal-title":"J Steroid Biochem"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib163","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(02)04551-X","article-title":"Treatment of hyperandrogenic alopecia in women","volume":"79","author":"Carmina","year":"2003","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib164","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1210\/endo-97-1-52","article-title":"Antiandrogenic effect of spirolactones: mechanism of action","volume":"97","author":"Corvol","year":"1975","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib166","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-4731(88)90295-6","article-title":"Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture","volume":"31","author":"Luthy","year":"1988","journal-title":"J Steroid Biochem"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib167","first-page":"84","article-title":"Spironolactone and cimetidine in treatment of acne","volume":"68","author":"Hatwal","year":"1988","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib168","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2133.1988.tb02571.x","article-title":"Tolerance of spironolactone","volume":"118","author":"Hughes","year":"1988","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib169","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/120347540200600604","article-title":"Long-term safety of spironolactone in acne: results of an 8-year follow-up study","volume":"6","author":"Shaw","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2015.05.026_bib170","doi-asserted-by":"crossref","unstructured":"Plovanich M, Weng QY, Mostaghimi A. Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne. JAMA Dermatol. doi:10.1001\/jamadermatol.2015.34. Published online March 22, 2015.","DOI":"10.1001\/jamadermatol.2015.34"},{"issue":"10","key":"10.1016\/j.jaad.2015.05.026_bib171","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjmed.2014.04.017","article-title":"Polycystic ovary syndrome: update on diagnosis and treatment","volume":"127","author":"Setji","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2015.05.026_bib172","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1186\/1757-1626-0002-0000007521","article-title":"Virilizing ovarian steroid cell tumor in a 40 year old South Indian female: a case report","volume":"2","author":"Salim","year":"2009","journal-title":"Cases J"},{"issue":"11","key":"10.1016\/j.jaad.2015.05.026_bib173","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/oxfordjournals.humrep.a135831","article-title":"A paradoxical inhibition of androgenic hyperproduction by a Sertoli-Leydig cell tumor ovary","volume":"10","author":"Amato","year":"1995","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib174","first-page":"261","article-title":"Guillermina Velasco Diaz G, Carranza Lira S. Virilizing adrenal adenoma: a report of a case [in Spanish]","volume":"73","author":"Mac Gregor Gooch","year":"2005","journal-title":"Ginecol Obstet Mex"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib175","first-page":"113","article-title":"A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary [in Portuguese]","volume":"23","author":"Marcelino","year":"2010","journal-title":"Acta Med Port"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib176","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.jpag.2008.06.002","article-title":"Virilizing luteinized thecoma of the ovary in a 15-year-old female: a\u00a0case report","volume":"22","author":"McGee","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib177","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4103\/2230-8210.100658","article-title":"Ovarian granulosa cell tumor: An uncommon presentation with primary amenorrhea and virilization in a pubertal girl","volume":"16","author":"Kota","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib178","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.2011.04160.x","article-title":"The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome","volume":"76","author":"Harrison","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib179","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.beem.2006.02.001","article-title":"Mild androgen phenotypes","volume":"20","author":"Carmina","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib181","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000277640","article-title":"Prevalence of polycystic ovary syndrome and related disorders in Mexican women","volume":"69","author":"Moran","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jaad.2015.05.026_bib182","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7827-9-39","article-title":"The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study","volume":"9","author":"Tehrani","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib183","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/eje.0.1390421","article-title":"Prevalence of idiopathic hirsutism","volume":"139","author":"Carmina","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib184","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib185","first-page":"311","article-title":"Etiological review of\u00a0hirsutism in 250 patients","volume":"25","author":"Mor\u00e1n","year":"1994","journal-title":"Arch Med Res"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib186","first-page":"354","article-title":"Should androgen levels be measured in hirsute women with normal menstrual cycles?","volume":"37","author":"Mehta","year":"1992","journal-title":"Int J Fertil"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib187","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.fertnstert.2004.06.040","article-title":"Prevalence of\u00a0endocrine diseases and abnormal glucose tolerance tests\u00a0in 340 Caucasian premenopausal women with hirsutism\u00a0as the referral diagnosis","volume":"82","author":"Glintborg","year":"2004","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib188","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib189","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000358485","article-title":"Prevalence of the polycystic ovary syndrome in female residents of Chengdu, China","volume":"77","author":"Zhuang","year":"2014","journal-title":"Gynecol Obstet Invest"},{"issue":"7","key":"10.1016\/j.jaad.2015.05.026_bib190","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asunci\u00f3n","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jaad.2015.05.026_bib191","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib192","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejogrb.2007.12.018","article-title":"Prevalence of polycystic ovary syndrome in unselected women from southern China","volume":"139","author":"Chen","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib193","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/aje\/kwn137","article-title":"A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka","volume":"168","author":"Kumarapeli","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib194","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.jaad.2015.05.026_bib195","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2004-821307","article-title":"A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue","volume":"112","author":"Unluhizarci","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib196","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1523-1747.ep12874121","article-title":"Androgen excess in women with acne alone compared with women with acne and\/or hirsutism","volume":"94","author":"Vexiau","year":"1990","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib197","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1346-8138.1997.tb02778.x","article-title":"Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne","volume":"24","author":"Timpatanapong","year":"1997","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib198","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/humrep\/deh048","article-title":"The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation","volume":"19","author":"Jones","year":"2004","journal-title":"Hum Reprod Oxf Engl"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib199","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00404-012-2568-z","article-title":"Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study","volume":"287","author":"Zhang","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/00016340903353284","article-title":"Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism","volume":"89","author":"Ozdemir","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"10.1016\/j.jaad.2015.05.026_bib201","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/humrep\/17.9.2219","article-title":"What is polycystic ovary syndrome? Are national views important?","volume":"17","author":"Balen","year":"2002","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib202","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaad.2013.09.014","article-title":"Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study","volume":"69","author":"Dalamaga","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"5-6","key":"10.1016\/j.jaad.2015.05.026_bib203","first-page":"251","article-title":"The SAHA syndrome","volume":"54","author":"Orfanos","year":"2000","journal-title":"Horm Res"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib204","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.clindermatol.2013.11.005","article-title":"Acne as a chronic systemic disease","volume":"32","author":"Zouboulis","year":"2014","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib205","first-page":"527","article-title":"Evaluating hyperandrogenism: a challenge in acne management","volume":"7","author":"Harper","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib206","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0015-0282(99)00383-0","article-title":"Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study","volume":"72","author":"Azziz","year":"1999","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib207","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"Speiser","year":"1985","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib208","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-09-0627","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline: commentary from a European perspective","volume":"163","author":"Guignat","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.jaad.2015.05.026_bib209","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1210\/jc.2003-030254","article-title":"Occult Cushing's syndrome in type-2 diabetes","volume":"88","author":"Catargi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib210","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2265.1996.737558.x","article-title":"Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycemic control in obese diabetic patients","volume":"44","author":"Leibowitz","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib211","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Guidelines for acromegaly management: an update","volume":"94","author":"Melmed","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","article-title":"Epidemiology of acromegaly in the Newcastle region","volume":"12","author":"Alexander","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.jaad.2015.05.026_bib213","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib214","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2265.2008.03221.x","article-title":"High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels","volume":"69","author":"Schneider","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.det.2007.01.005","article-title":"Drug reactions affecting hair: diagnosis","volume":"25","author":"Tosti","year":"2007","journal-title":"Dermatol Clin"},{"issue":"9","key":"10.1016\/j.jaad.2015.05.026_bib216","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/clinchem\/38.9.1685","article-title":"Detecting testosterone administration","volume":"38","author":"Catlin","year":"1992","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib217","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1210\/jc.2002-021231","article-title":"Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension","volume":"88","author":"Storer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib218","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib219","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1469-8986.1989.tb01917.x","article-title":"Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors","volume":"26","author":"Saab","year":"1989","journal-title":"Psychophysiology"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib220","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2265.1992.tb01457.x","article-title":"Age\u00a0related changes in follicle stimulating hormone, luteinizing hormone, estradiol and immunoreactive inhibin in women of reproductive age","volume":"36","author":"MacNaughton","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib221","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0015-0282(00)00631-2","article-title":"Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia","volume":"74","author":"Huerta","year":"2000","journal-title":"Fertil Steril"},{"issue":"25 Pt A","key":"10.1016\/j.jaad.2015.05.026_bib222","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.jacc.2014.02.606","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"63","author":"Andrus","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaad.2015.05.026_bib223","first-page":"1","article-title":"Screening for glucose intolerance in polycystic ovary syndrome: hemoglobin A1C, fasting blood glucose or oral glucose tolerance test?","author":"Kelley","year":"2014","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib224","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3949\/ccjm.57.5.423","article-title":"Diagnostic approach to androgen disorders in women: acne, hirsutism, and alopecia","volume":"57","author":"Redmond","year":"1990","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"10.1016\/j.jaad.2015.05.026_bib225","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/jc.2002-020922","article-title":"The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women","volume":"88","author":"Kaltsas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jaad.2015.05.026_bib226","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/1933719114522525","article-title":"Prevalence of polycystic ovary syndrome phenotypes using updated criteria for polycystic ovarian morphology: an assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome","volume":"21","author":"Clark","year":"2014","journal-title":"Reprod Sci"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib227","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/humrep\/deg115","article-title":"Ultrasound examination of polycystic ovaries: is it worth counting the follicles?","volume":"18","author":"Jonard","year":"2003","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib228","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O'Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"10.1016\/j.jaad.2015.05.026_bib229","first-page":"1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly\u20132011 update","volume":"17","author":"Katznelson","year":"2011","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib230","first-page":"CD004684","article-title":"Laser and photoepilation for unwanted hair growth","author":"Haedersdal","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib231","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2006.09.025","article-title":"A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women","volume":"57","author":"Hamzavi","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib232","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-4632.2006.03079.x","article-title":"Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair","volume":"46","author":"Wolf","year":"2007","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib233","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2009.02.016","article-title":"Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled phase III trial","volume":"80","author":"Plewig","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib234","first-page":"89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib235","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0015-0282(16)57727-9","article-title":"Clinical and endocrine\u00a0effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism","volume":"64","author":"Ciotta","year":"1995","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.jaad.2015.05.026_bib236","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1210\/jc.2006-2798","article-title":"Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial","volume":"92","author":"Calaf","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jaad.2015.05.026_bib237","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib238","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","article-title":"Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome","volume":"60","author":"Gambineri","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib239","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/jc.2006-2684","article-title":"Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess","volume":"92","author":"Ib\u00e1\u00f1ez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib240","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jaad.2015.05.026_bib241","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jaad.2015.05.026_bib242","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin\u00a0improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial","volume":"97","author":"Morin-Papunen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.jaad.2015.05.026_bib243","first-page":"3412","article-title":"Comparison of a gonadotropin-releasing hormone agonist and a low dose\u00a0oral contraceptive given alone or together in the treatment of hirsutism","volume":"80","author":"Heiner","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jaad.2015.05.026_bib244","first-page":"CD008565","article-title":"Statins for women with polycystic ovary syndrome not actively trying to conceive","author":"Raval","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib245","first-page":"CD001125","article-title":"Cyproterone acetate for hirsutism","author":"Van der Spuy","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2015.05.026_bib246","first-page":"109","article-title":"Treatment of hirsutism in polycystic ovarian syndrome with Diane, 50 mcg ethinyl estradiol and 2 mg cyproterone acetate","volume":"9","author":"Saeed","year":"1993","journal-title":"Specialist"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2015.05.026_bib247","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.05.026_bib248","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2014.03.051","article-title":"Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris","volume":"71","author":"Koo","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.05.026_bib249","first-page":"299","article-title":"Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol","volume":"7","author":"Cremoncini","year":"1976","journal-title":"Acta Eur Fertil"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib250","first-page":"189","article-title":"Female pattern hair loss: current treatment concepts","volume":"2","author":"Dinh","year":"2007","journal-title":"Clin Interv Aging"},{"issue":"2","key":"10.1016\/j.jaad.2015.05.026_bib251","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2133.2001.04018.x","article-title":"Hair density, hair diameter and the prevalence of female pattern hair loss","volume":"144","author":"Birch","year":"2001","journal-title":"Br J Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2015.05.026_bib252","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0190-9622(99)70006-X","article-title":"Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment","volume":"41","author":"Price","year":"1999","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215017259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215017259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:36:02Z","timestamp":1759271762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215017259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":252,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0190962215017259"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.05.026","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-based approach to cutaneous hyperandrogenism in women","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}